RK
Robert P Khederian
Director

Robert P Khederian insider trades: Inverness Medical Innovations (IMA) stock buys and sales

Director, Inverness Medical Innovations Last trade Jun 16, 2009 19 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2005
4
Companies
last trade 2009

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 16, 2009IMA↓ Sell$819K
Feb 26, 2009IMA↓ Sell$598K
Dec 1, 2008IMA↓ Sell$85K
Nov 21, 2008IMA↓ Sell$1.4M
Jun 5, 2008IMA↑ Buy$193K
Nov 19, 2007CAMH↑ Buy$73K
May 25, 2007CAMH↑ Buy$204K
May 15, 2007CAMH↑ Buy$189K
Sep 11, 2006CAMH↑ Buy$353K
Feb 22, 2006CAMH↓ Sell$641K
Jun 10, 2005CAMH↑ Buy$53K
Jun 1, 2005CAMH↑ Buy$51K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other IMA insiders

Open-market trades in the last 12 months

About Robert P Khederian's insider trades

Robert P Khederian is a director at Inverness Medical Innovations (IMA). Since Jun 1, 2005, Robert has reported 7 open-market purchases worth $1.1M and 5 sales worth $3.6M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (5 filings), option exercises (4 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.